We then investigated whether the altered ROS profile of AML CD34+SPCs is also adapted in the immunophenotypically more mature CD34− blast compartment from CD34− AML samples (defined as cases where <5% blasts cells are CD34+) (n = 23). The gene discussed is CD34; the disease is acute myeloid leukemia.